|
|
|
|
Review Article
|
|
Epigenetic Effects of Carcinogens
|
|
Ali Vaziri Gohar
and
Abbas Mohammadi
|
|
|
ABSTRACT
|
The strategies for reduction of carcinogenic factors exposure can reduce the risk of most cancer types. Millions of people around the world get exposed to high levels of heavy metals in the drinking-water. Therefore, quality control in drinking-water and detection of its heavy metals is extremely critical issue. The carcinogenicity of aluminum, arsenic, chromium, nickel and selenium has been documented previously, but in a scattered fashion. Trace amount of these elements can induce genetic and epigenetic alterations in different cancer-related genes of somatic and stem cells, thus involved in cancer stem cell formation. Through epigenetic effects of these elements have more prominent role than their genetic effects, these elements are able to change the pattern of cancer-related genes expression profiles, too. Therefore, understanding the underlying epigenetically mechanisms of these trace elements can reduce their toxicities duo to individual and social preventive behaviors. It seems that the toxic effects of these elements in many regions are predictable, but antioxidant supplements eliminate the reactive oxygen species as leading effects of these elements.
|
|
|
|
|
Received: October 30, 2009;
Accepted: February 08, 2010;
Published: March 17, 2010
|
|
INTRODUCTION The importance of cancer prevention has led to detection and elimination of environmental carcinogenic agents. Many carcinogens have already been identified and the relevant information with regard to these agents is available. However, humans use many food and beverage items, assuming that they are safe. One example is the potentially harmful presence of heavy metals that can cause serious health problems. People may be exposed to heavy metals over the course of their lifetime. The heavy metals in drinking-water pose the greatest threat to public health in this regard. This necessitates setting suitable quality control procedures.
The main source of heavy metals in drinking-water is contamination of surface
and ground waters by industrial sewage and agricultural run-off (Karavoltsos
et al., 2008).
In the areas that the water distribution network is made of alloys containing
heavy metals, some people may not afford bottled or mineral water with controlled
heavy metal concentrations and they consume tap water, therefore the possibility
of contamination of drinking-water with heavy metals greatly increases (Leivadara
et al., 2008).
According to some WHO reports, the concentration of these elements in ground
water is high in several countries including Bangladesh, India and Argentina
(WHO, 2003).
Heavy metals in drinking-water are toxic and can easily enter the body. The
genetic and epigenetic effects of these elements are associated with an increased
risk of different cancer types (Bower et al., 2005).
Epigenetic mechanisms play an equally important if not a more prominent role
than genetic events in carcinogenesis. These effects occur most frequently during
the early stages of tumor development. Epigenetic events include reversible
modifications of histone proteins and CpG islands of gene promoters that affect
not only gene expression of germ and somatic cells, but also cause indirect
gene-sequence changes (Jones and Baylin, 2002; Vaziri
Gohar et al., 2007).
CpG islands (5'-CG-3' sequence) exist in about 40% of mammalian genes. Hypermethylation
or hypomethylation of C5 position of the cytosine base are involved in the inhibition
of expression of tumor suppressor genes or the increase of the oncogene expression,
both of which contribute to cancer development and progression (Kinzler
and Vogelstein, 1997).
Gene silencing can also take place through methylation of lysine 9 in histone-H3
(H3-K9), which results in a cascade of clustering of several proteins including
HP1 protein, SUV39H1 histone methyltransferase, histone deacetylases, DNA Methyl
transferases and finally methyl-C binding proteins (MBD) (Tamaru
and Selker, 2001; Jackson et al., 2002; Vogelstein
and Kinzler, 2004).
Methylated cytosine may be spontaneously deaminated to produce a thymine, resulting
in a specific transition mutation in CpG islands, for example in the TP53
tumor suppressor gene as a guard of genome. In addition, hypermethylation of
histone proteins causes changes in the chromatin configuration, predisposing
cells to allelic loss at a specific locus in the chromosomes (Egger
et al., 2004). Such genetic and epigenetic alterations in growth-control
genes such as DNA-repair genes, tumor suppressor genes, oncogenes, apoptotic
genes, combine to determine the cellular phenotype and differentiation (Vaziri
Gohar et al., 2007; Mohammadi et al.,
2008).
In ranking the carcinogens, heavy metals have been classified by the International
Agency for Research on Cancer (IARC) and Environmental Protection Agency (EPA)
as the first group, except for selenium that has been listed within group 3
(not carcinogen to humans) of the IARC classification (IARC,
1989).
The goal of this review was the introduction and comparison of epigenetic effects caused by the following elements in cancer-related genes in biological systems and show that the incidence of cancer can be reduced by adopting prevention behavior especially in terms of drinking-water.
Aluminum: The compounds of this element have a wide range of applications
in different industries, including cosmetics and food additives (Laden
and Felger, 1988).
Aluminum-induced carcinogenesis is related to its ability to bind to the estrogen
receptor and mimic estrogen functions, therefore its named metalloestrogen (Darbre,
2005). Metalloestrogen triggers expression in genes that contain Estrogen
Responsive-Element (ERE) on their promoters. In mammary gland cells, this gives
rise to an increase in the number of divisions of breast cells, thus increasing
replication errors in cancer-related genes (Sun et al.,
2007).
It has been shown that if antiperspirants containing aluminum applied on the
skin around the underarm and breast areas are not effectively washed, some aluminum
salts remains in the area. This gives rise to continuous exposure and enhances
the risk of breast cancer (Stellman et al., 2000).
There are two different groups of Estrogen Receptors (ER). The first group
exist in cytosol/nucleus (ER-α and ER-β) and act as transcription
factors by directly binding to ERE. The second group exists in plasma membrane
as transmembrane G-protein coupled receptors. This kind of ERs can also regulate
gene expression through interaction with other transcription factors, without
directly binding to ERE. Plasma membrane located ER46 is involved in endothelial
Nitric Oxide Synthase (eNOS) phosphorylation and rapid Nitric Oxide (NO) release
via phosphatidyl inositol 3-kinase in endothelial cells. Another plasma membrane
located ER family called ER66 regulates reporter gene expression (Darbre,
2005).
Aluminum can bind to both nuclear and membrane ERs and ERE; as a result, it
can activate both ER signal transductions. Therefore, as expected, Al3+
treatment results in intracellular NO generation (Satoh
et al., 2007).
In addition to breast carcinogenesis, estrogen can activate telomerase gene
expression as a gene containing ERE, in ER-α positive cells, but not in
ER negative cells, this results in endometrial cancer (Harley,
2008).
Epigenetic effects of aluminum take place through the binding of trivalent
(Al3+) to the phosphate groups of double stranded DNA under physiologic
pH, thus changing DNA topology from B to Z in (CCG)12 repeat regions
(Zhang et al., 2002).
The expansion of the triplet repeats is named dynamic mutation and may be localized
both in coding and non-coding regions. A minimum of 5-10 triplet-repeats increases
the probability of hairpin formations, mainly in the lagging strand. Movement
of DNA polymerase along the hairpin structure leads to replication slippage
and genomic instability, causing deletion mutations. Expansion of more than
200 copies of these repeats leads to excessive methylation of cytosines in the
promoter of FMR1 gene which results in fragile X syndrome (Lukusa
and Fryns, 2008).
Arsenic: Arsenic is mostly known as an epigenetic carcinogen metalloid
when in the form of an inorganic compound. Trivalent arsenite (As3+)
has more carcinogenic properties than the pentavalent arsenate (As5+)
(Patterson et al., 2003; Alkahtani,
2009). Trivalent arsenic can bind with high affinity to thiol groups of
proteins and reduced glutathione (GSH) (Suzuki et al.,
2004).
Long time uptake of drinking-water containing low levels of arsenite, induces
carcinogenesis in skin, lung, bladder and kidney tissues, resulting from alteration
in multiple signaling pathways (Jensen et al., 2009).
The risk of bladder cancer in people drinking water with an arsenic level above
100 ppb increases over 15 times compared with people living in areas with less
than 10 ppb (Vahter, 2002).
Arsenic is methylated for detoxification and excretion from the body. It is
exactly this reaction that gives rise to the carcinogenic properties of arsenic
through epigenetic transformations. This is contrary to the general belief that
considers the methylation as a way for detoxification. The toxicity of monomethyl
arsenic (MMAs) and dimethyl arsenic (DMAs) is more than arsenite (Patterson
et al., 2003; Suzuki et al., 2004).
Arsenic methylation occurs by Glutathione S-Transferase (GST), arsenic III
methyltransferase (AS3MT) and S-Adenosyl Methionine (SAM). These enzymes compete
with DNA methyltransferase (DNMT) for DNA methylation, hence, inhibiting DNA
methyltransferase indirectly and inducing the reactivation of silenced tumor
suppressor genes (Huang, 2002).
Exposure to arsenic induces the ROS formation (through its reduction) as an
unavoidable reaction of normal cell metabolism (Galaris
et al., 2008).
ROS, acting as a second messenger, are involved in the activation of PI3K/Akt
pathway and the subsequent induction of transcription factor hypoxia inducible
factor-1 (HIF-1α) but not HIF-1β and Vascular Endothelial Growth Factor
(VEGF) induction (Gao et al., 2004; Galanis
et al., 2008).
Another important mechanism of arsenic induced carcinogenesis is through enhancing
the genotoxicity of other carcinogens, including ultraviolet radiation (UVR),
ionizing radiation, alkylating agents, or oxidants. UVR induces non-melanoma
skin cancer. Strands of DNA exposed to photons of UVA and UVB break and Cyclobutane
Pyrimidine Dimers (CPDs) are formed (Ravanat et al.,
2001; Melnikova and Ananthaswamy, 2005).
UVRs can activate a zinc-finger protein family poly (ADP-ribose) polymerase
(PARP), particularly one member of this family named PARP-1, has an important
role in the regulation of Nucleotide Excision Repair (NER). CPDs have been identified
in p53 and PTCH tumor suppressor genes and ras oncogenes (Rossman
et al., 2001, 2002).
Arsenite stimulates inducible Nitric Oxide Synthase (iNOS) expression and NO
production through mammalian mitogen-activated protein kinases p38 and activation
of nuclear transcription factor-kappa B (NF-κB) (Ding
et al., 2008).
Between 40-60% of arsenic intake is excreted into the urine (Fujihara
et al., 2009). A major proportion of urinary arsenic is composed
of dimethylated arsenic (Vahter, 2000).
Chromium: Trivalent chromium is an epigenetic carcinogen factor since,
it can form stable compounds with macromolecules such as DNA and cysteine residue
of proteins and glutathione (Zhitkovich et al., 1995).
The trivalent form of chromium cannot pass the cell membrane; however, the
hexavalent salts are able to enter the cell and are converted to the trivalent
form (Alexander and Aaseth, 1995).
Thus, depending on the situation, reducing agents can affect carcinogenic properties
of chromium and inside the cell, chromium (VI) can be converted to a carcinogen.
During Cr (VI) reduction, many compounds such as oxygen radicals, DNA Inter-strand
Cross Links (ICLs) and Single-Strand Breaks (SSBs) may form.Inter-strand Cross
Links act as physical barriers to DNA replication and transcription events,
thus inducing apoptosis (Schnekenburger et al., 2007).
The chromium carcinogenicity, particularly in lung epithelial cells and fibroblasts,
is imposed through hypermethylation of CYP1a1 promoter. Chromium recruits histone
deacetylase 1 (HDAC1) and DNMT1, especially to CYP1a1 promoter and this assembly
recruits BP1 and inhibits CYP1a1 gene expression (Wei et
al., 2004).
The CYP1A1 is important in the metabolism of carcinogens such as Polycyclic
Aromatic Hydrocarbons (PAHs) and heterocyclic amines that are widely distributed
widely in our environment through automobile exhausts, cigarette smoke, charcoal-broiled
cooking and industrial waste. In contrast to other cytochrome P450 enzymes such
as epoxide hydrolase and dihydrodiol dehydrogenase that are involved in PAH
and Benzo(a)pyrene-induced carcinogenesis, CYP1A1 inhibits PAH carcinogenesis.
Thus, inhibition of CYP1A1 by chromium leads to the production of a PAH (Wu
et al., 2008).
PAHs have an important role in the activation of cytosolic ligand-activated
transcription factor named Aromatic hydrocarbon Receptor (AhR) (Nebert
et al., 2000). After formation, the PAH-AhR complex transfer into
the nucleus. In the nucleus, PAH is detached from the complex and AhR binds
to its nuclear partner, Arnt. This new complex acts as a transcription factor
and interacts with DRE of CYP1A1 gene, leading to the activation of CYP1A1 gene
expression, thus causing bioactivation of exogenous procarcinogens of both hepatocellular
and lung carcinomas (Li et al., 2009).
It is interesting that PAH through binding to transcription factor AhR, activates
CYP1a1 gene expression and CYP1A1 inhibits PAH carcinogenesis, but in the presence
of Cr, the promoter of CYP1a1 is inactivated and PAH can act as carcinogens
(Wei et al., 2004).
Benzo(α)pyrene is also a member of Polycyclic Aromatic Hydrocarbon (PAHs)
family that is metabolically transformed from its pro-carcinogenic status to
the carcinogenic metabolite (BP-7,8-dihydrodiol-9,10-epoxide (BPDE)), that can
binds covalently to DNA and forms BPDE-DNA adduct and ROS. The BPDE activates
apoptosis through p53 independent and dependent manner (Drukteinis
et al., 2005).
P53 dependent Cr-induced apoptosis takes place by increasing p53 phosphorylation
at Ser392, as well as up-regulation of pro-apoptotic gene bcl-XS and caspase-7
and down-regulation of several anti-apoptotic genes from Bcl2-family (bcl-W
and bcl-XL) and bax. These apoptotic events result in the destruction of the
mitochondria and release of cytochrome c (Blankenship et
al., 1994; Carlisle et al., 2000; Ceryak
et al., 2004). Moreover, Cr induces the ATM protein production, which
phosphorylates and activates Chk2 protein. The phosphorylated Chk2
in turn phosphorylates and activates p53. The phosphorylated p53 does not bind
to MDM2 protein (Ha et al., 2003; Vaziri
Gohar et al., 2007).
Cr exposure at very high concentrations activates all subclasses of MAPK through
phosphorylation; therefore, Cr acts as a MAPK kinase and increases survival/proliferation
in a dose-dependent manner. This function is associated with its ability in
ROS generation (Thomas, 1992; Gao
et al., 2002).
Nickel: Water-insoluble nickel compounds including nickel sulfides,
disulfides and oxides readily enter the cell and are very potent carcinogens
(Dunnick et al., 1995). In contrast, water-soluble
nickel compounds including acetate, chloride, nitrate and sulfate do not enter
the cells as readily as water-insoluble nickel compounds (Abbracchio
et al., 1982).
The increase in the usage of nickel compounds and the spread of nickel due
to its dissolution from nickel ore-bearing rocks are the main causes of nickel
presence in the environment. The primary source of nickel in drinking-water
is the leaching of metals in water network (WHO, 2005).
However, food is the major source of nickel exposure in the non-smoking, non-occupationally
exposed population, but nickel absorption from water was significantly higher
than absorption of nickel from beverages like tea, coffee, or orange juice and
milk (Nielsen et al., 1999).
Ni2+ induces carcinogenesis through several processes including
DNA hypermethylation, DNMT inhibition, DNA mutation, ROS generation, inhibiting
histone H2A, H2B, H3 and H4 acetylation, converting the tumor suppressor genes
to the heterochromatin and substantial increases of the ubiquitination of H2A
and H2B (Ke et al., 2008). Therefore, nickel
plays an important role in silencing of genes (Lee et
al., 1998).
Nickel binds to DNA in different positions. It binds to phosphate backbone
of DNA in place of Mg and promotes the conversion of suppressor genes to the
heterochromatin (Cangul et al., 2002). Moreover,
its binding to histone H4 leads to the inhibition of lysine acetylation
and subsequently DNA hypermethylation (Broday et al.,
2000).
These events play an important role in silencing of tumor suppressor genes and the other genes that are involved in carcinogenesis pathways.
Selenium: Selenium is an essential trace element with a narrow range
between toxic and therapeutic doses; its activity is therefore highly dose dependent.
Enzymes containing selenium such as glutathione peroxidase like other antioxidant
elements can protect body from oxidative damage and reduce the risk of cancer
incidence and mortality through several pathways such as apoptosis and alteration
of some collagen types (Rayman, 2000).
Since selenium, like arsenic is detoxified by methylation through S-adenosylmethionine
pathway, competition between arsenic, selenium and DNMT1 for methyl donated
by S-adenosylmethionine leads to DNA hypomethylation and an increase in arsenic
retention in tissues (Xiang et al., 2008).
Organic selenium compounds such as selenomethionine, Se-methyl-selenocysteine
(Se-MSC) and particularly Selenocystine (SeC), have shown more anticarcinogenic
activity than inorganic compounds in lung cancer model systems. However, in
contrast to selenomethionine, selenocystine decreases cellular reduced thiol
agents like N-acetylcysteine (NAC) and GSH, thus increasing the ROS formation
(Zou et al., 2008). Selenium-containing proteins
can induce apoptosis pathway through caspase activation. But, selenite, SeC
and selenomethionine mostly activate apoptosis by caspase-independent pathways
through p53 activation and anti-apoptotic inactivation and release of cytochrome
c from mitochondria as follows. First, these compounds increase production of
reactive oxygen species. ROS-mediated modified products such as DSBs, are detected
by ATM and ATR proteins, which in turn can activate p53 in MCF-7 human breast
cancer cells and human prostate cancer. These DSBs can even synergistically
increase the intracellular ROS production. Second, they induce p53 phosphorylation
at Ser15, Ser20 and Ser392 residues, thus decreasing
p53-MDM2 protein interaction and p53 stability (Chen and
Wong, 2008).
The Se-MSC shows its anticarcinogenic activity through down regulation of some
extracellular matrix proteins such as collagen type I alpha 1 (COL1A1),
COL1A2 and COL7A1 and up-regulation
of COL6A1 and COL4A5 genes in human
prostate cell line (Hurst et al., 2008).
DISCUSSION
Heavy metal-induced carcinogenesis is the cause of death in some countries
with concentrations greater than global standard levels. Also, analysis of heavy
metals in archival Formalin-Fixed Paraffin-Embedded (FFPE) tissue specimens
showed the possible roles of these elements in cancer development, so detecting
and removal of heavy metal from tap and bottled drinking-waters needs special
attention (Asadikaram et al., 2008; Sarafanov
et al., 2008; Vaziri Gohar and Mohammadi, 2009).
In most populations, the main source of heavy metal entrance to the body may
not be drinking water, but this is an important route (WHO,
2003).
In spite of the important role of heavy metals in the deviation of cell growth toward carcinogenesis, some of these elements such as selenium, arsenite and chromium have anticarcinogenic effects.
Selenium containing compounds that serve as antioxidants have an important
role in prevention and attenuation of toxic effects of other heavy metals and
their deficiency leads to Keshan and Kaschin-Beck diseases (Rayman,
2000). Using 15 mg kg-1 sodium selenite fortified-salt for 6
years resulted in decrease of hepatocellular carcinoma (HCC) incidence in humans
(Yu et al., 1999).
Arsenite is involved in the treatment of Acute Promyelocytic Leukaemia (APL)
and hematological malignancies (Bachleitner-Hofmann
et al., 2002). Cr-exposure causes reduction of the proliferative ability
of human lymphoblast cell lines (Zhang et al., 2002).
Chromium also has an application in individuals with impaired glucose tolerance.
SeC and chromium are effective against lung tumors induced by a compound named
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) (Kasprzak
and Buzard, 2000).
Figure 1 shows a summary of cellular events which are attached
be heavy metals. The major DNA lesions associated with heavy metal exposure
result from production of ROS, DNA base damage, strand breaks, apurinic sites
and cross-links (Kasprzak and Buzard, 2000). The ROS
are products of heavy metal reduction. Thus, the reducing conditions like acidic
condition in the stomach, extracellular ascorbic acid and GST activity can be
involved in heavy metal-induced carcinogenesis.
ROS induce a heterodimeric helix-loop-helix transcription factor HIF-1 (Imamura
et al., 2009). HIF-1 expression gives rise to resistance to chemotherapy
and radiotherapy. The expression of HIF occurs in several human cancers, such
as prostate and Sporadic Clear Cell Renal Cell Carcinoma (SCRCC). Also, HIF
production leads to up-regulation of VEGF and thus, tumor angiogenesis (Gordan
et al., 2008).
| Fig. 1: | Epigenetic
pathway of heavy metals in human. Schematic representation of heavy metal
signaling pathways which lead to carcinogenesis. Individual pathways are
discussed in the text (Cowell, 2001; Vaziri
Gohar et al., 2007) |
The Von Hippel-Lindau tumor suppressor protein (VHL) inhibits VEGF formation
by inhibition of hypoxia-inducible factors. Therefore, loss of VHL tumor suppressor
gene function promotes tumor cell invasion, which has an important role in familial
and most sporadic clear cell renal cell carcinoma and prostate tumorigenesis
(Monsef et al., 2007).
Besides ROS, heavy metals can induce NO production. NO exposure can alter and
damage DNA molecule, thus promoting p53 post-translation and accumulation. Therefore,
as expected, inhibition of iNOS gene activity is involved in heavy metal-induced
carcinogenesis (Hussain et al., 2003).
ROS also can act as mediators of NF-kB activation (Monsef
et al., 2007). This transcription factor is involved in carcinogenesis
by inhibition of the apoptosis pathway and also can induce cyclin D1 gene (Guttridge
et al., 1999). Cyclin-D1 is one of the important targets that has
underlying role in the estradiol and metalloestrogen-induced proliferations.
Binding of Aluminum as a metalloestrogen to ERs has different effects on cyclin-D1
expression, e.g. binding to ER-α increase and binding to ER-β represses
the expression level. Activation of cyclin-D1 as a protein of G1 phase of cell
cycle followed by cyclin-E leads to the inactivation of pRB1 via phosphorylation,
thus permits the cell to enter the S phase of the cell cycle (Guttridge
et al., 1999; Leader et al., 2006).
Exposure to low level of MMAs3+ induces malignancy through
irreversible epigenetic activation of a member of the non-canonical WNT signaling
pathway, named WNT5A tumor suppressor gene. Therefore, this arsenic form mediates
the activation of PKC, hence alteration of the intracellular calcium levels.
WNT5A gene has a tumor suppressive function, but up-regulation of this gene
is involved in stomach, pancreas, bladder, melanoma and glioblastoma malignancies.
The activation of WNT5A transcription correlates with the enrichment of permissive
histone modifications and the reduction of repressive modifications in the WNT5A
promoter region (Jensen et al., 2009).
One enzyme family involved in heavy metal metabolism is cysteine-rich enzymes
called metallothioneins (MTs). This enzyme family as an antioxidant, act as
a scavenger of heavy metals and ROS. It is interesting that besides zinc, cadmium
can also induce expression of this enzyme (Majumder et
al., 2006). Another enzyme family with dual-functional is GST that in
one side, can methylate and detoxify heavy metals through faster excretion,
on the other side they may accelerate the reduction of these elements and increase
their carcinogenicities (Adams et al., 2002).
Another mechanism that these elements affect the body is through their effects
on stem cells. Stem cells with long lifetime such as embryonal, germinal and
progenitor cells have a high opportunity for epigenetic and genetic accumulations.
Epigenetic alterations of growth-control genes in the stem cells change the
cellular differentiation. Therefore, heavy metal exposures in pregnancy, especially
through drinking-water can transfer the metals to the fetus and make instable
stem cells that have been defined as cancer stem cells which can result in abnormal
cell expansion in the precancerous stage of tumor development (Sell,
2004). These cancer stem cells have first been detected in transmissible
mice leukemia and have been reported in several types of malignancies such as
brain, breast, colon and melanoma (Zhang and Rosen, 2006).
CONCLUSION
The heavy metals ability in ROS and NF-kB production and also human genetic
differences through polymorphisms in glutathione S-transferase, metallothioneins
and methyltransferase genes induce carcinogenesis. Many of these results may
eliminate by daily antioxidant usage (Evans, 2008).
The recommended dose of intake for adults by Recommended Dietary Allowance (RDA)
for zinc, chromium and selenium is 11 mg, 25 and 55 μg.
This review shows that these heavy metals are carcinogen, particularly epigenetic carcinogen and might be solely responsible for tumors presentation and progression. The importance of these elements in cancer stem cell development give rise to the understanding other roles of these carcinogens and detection of possible removal drinking-water heavy metals by future research.
|
REFERENCES |
1: Abbracchio, M.P., J.D. Heck and M. Costa, 1982. The phagocytosis and transforming activity of crystalline metal sulfide particles are related to their negative surface charge. Carcinogenesis, 3: 175-180. Direct Link |
2: Adams, T.K., N. Saydam, F. Steiner, W. Schaffner and J.H. Freedman, 2002. Activation of gene expression by metal-responsive signal transduction pathways. Environ. Health Perspect., 110: 813-817. Direct Link |
3: Alexander, J. and J. Aaseth, 1995. Uptake of chromate in human red blood cells and isolated rat liver cells: The role of the anion carrier. Analyst, 120: 931-933. Direct Link |
4: Alkahtani, S., 2009. Antioxidation and hypomethylation effects on genotoxicity and programmed cell death induced in mice somatic cells by arsenic trioxide. J. Biol. Sci., 9: 721-729. CrossRef | Direct Link |
5: Bachleitner-Hofmann, T., M. Kees and H. Gisslinger, 2002. Arsenic trioxide: Acute promyelocytic leukemia and beyond. Leuk. Lymphoma, 43: 1535-1540. PubMed |
6: Blankenship, L.J., F.C. Manning, J.M. Orenstein and S.R. Patierno, 1994. Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol. Appl. Pharmacol., 126: 75-83. PubMed |
7: Bower, J., S. Leonard and X. Shi, 2005. Conference overview: Molecular mechanisms of metal toxicity and carcinogenesis. Mol. Cell Biochem., 279: 3-15. CrossRef |
8: Broday, L., W. Peng, M.H. Kuo, K. Salnikow and M. Zoroddu et al., 2000. Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res., 60: 238-241. Direct Link |
9: Cangul, H., L. Broday, K. Salnikow, J. Sutherland and W. Peng et al., 2002. Molecular mechanisms of nickel carcinogenesis. Toxicol. Lett., 127: 69-75. CrossRef |
10: Carlisle, D.L., D.E. Pritchard, J. Singh, B.M. Owens, L.J. Blankenship, J.M. Orenstei and S.R. Patierno, 2000. Apoptosis and P53 induction in human lung fibroblasts exposed to chromium(VI): Effect of ascorbate and tocopherol. Toxicol. Sci., 55: 60-68. Direct Link |
11: Ceryak, S., C. Zingariello, T. O'Brien and S.R. Patierno, 2004. Induction of pro-apoptotic and cell cycle-inhbiting gene in chromium (VI)-treated human lung fibroblasts: Lack of effect of ERK. Mol. Cell Biochem., 255: 139-149.
12: Chen, T. and Y.S. Wong, 2008. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation. Int. J. Biochem. Cell Biol., 41: 666-676. PubMed |
13: Darbre, P.D., 2005. Aluminium, antiperspirants and breast cancer. J. Inorganic Biochem., 99: 1912-1919. PubMed |
14: Ding, W., L.G. Hudso, X. Sun, C. Feng and K.J. Liu, 2008. As(III) inhibits ultraviolet radiation-induced cyclobutane pyrimidine dimer repair via generation of nitric oxide in human keratinocytes. Free Radiat. Biol. Med., 45: 1065-1072. CrossRef |
15: Drukteinis, J.S., T. Medrano, E.A. Ablordeppey, J.M. Kitzman and K.T. Shiverick, 2005. Benzo[a]pyrene, but Not 2,3,7,8-TCDD, Induces G2/M Cell Cycle Arrest, p21CIP1 and p53 Phosphorylation in human choriocarcinoma JEG-3 Cells: A distinct signaling pathway. Placenta, 26: S87-S95. Direct Link |
16: Dunnick, J.K., M.R. Elwell, A.E. Radovsky, J.M. Benson and F.F. Hahn et al., 1995. Comparative carcinogenic effects of nickel subsulfide, nickel oxide, or nickel sulfate hexahydrate chronic exposures in the lung. Cancer Res., 55: 5251-5256. Direct Link |
17: Egger, G., G. Liang, A. Aparicio and P.A. Jones, 2004. Epigenetics in human disease and prospects for epigenetic therapy. Nature, 429: 457-463. PubMed |
18: Evans, J., 2008. Antioxidant supplements to prevent or slow down the progression of AMD: A systematic review and meta-analysis. Eye, 22: 751-760. PubMed |
19: Fujihara, J., Y. Fujii, T. Agusa, T. Kunito, T. Yasuda, T. Moritani and H. Takeshita, 2009. Ethnic differences in five intronic polymorphisms associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene. Toxicol. Applied Pharmacol., 234: 41-46. CrossRef |
20: Galanis, A., A. Karapetsas and R. Sandaltzopoulos, 2008. Metal induced carcinogenesis, oxidative stress and hypoxia signaling. Mutat. Res. Genet. Toxicol. Environ. Mutagenesis, 674: 31-35. CrossRef |
21: Galaris, D., V. Skiada and A. Barbouti, 2008. Redox signaling and cancer: The role of labile iron. Cancer Lett., 266: 21-29. Direct Link |
22: Gao, N., L. Shen, Z. Zhang, S.S. Leonard and H. He et al., 2004. Arsenite induces HIF-1α and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol. Cell Biochem., 255: 33-45. Direct Link |
23: Gao, N., B.H. Jiang, S.S. Leonard, L. Corum and Z. Zhang et al., 2002. p38 signaling-mediated hypoxia-inducible factor 1α and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J. Biol. Chem., 277: 45041-45048. Direct Link |
24: Gordan, J.D., P. Lal, V.R. Dondeti, R. Letrero and K.N. Parekh et al., 2008. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell, 14: 435-446. PubMed |
25: Guttridge, D.C., C. Albanese, J.Y. Reuther, R.G. Pestell and A.S. Baldwin Jr., 1999. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell Biol., 19: 5785-5799. PubMed |
26: Ha, L., S. Ceryak and S.R. Patierno, 2003. Chromium (VI) activates ATM: Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem., 278: 17885-17894. Direct Link |
27: Harley, C.B., 2008. Telomerase and cancer therapeutics. Nat. Rev. Cancer, 8: 167-179. PubMed |
28: Huang, S., 2002. Histone methyltransferases, diet nutrients and tumour suppressors. Nat. Rev. Cancer, 2: 469-476. PubMed |
29: Hurst, R., R.M. Elliott, A.J. Goldson and S.J. Fairweather-Tait, 2008. Se-methylselenocysteine alters collagen gene and protein expression in human prostate cells. Cancer Lett., 269: 117-126. Direct Link |
30: Hussain, S.P., L.J. Hofseth and C.C. Harris, 2003. Radical causes of cancer. Nat. Rev. Cancer, 3: 276-285. CrossRef | Direct Link |
31: IARC, 1989. Monograph on Chromium, Nickel and Welding. IARC., Lyon, France.
32: Imamura, T., H. Kikuchi, M.T. Herraiz, D.Y. Park and Y. Mizukami et al., 2009. HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int. J. Cancer, 124: 763-771. PubMed |
33: Jackson, J.P., A.M. Lindroth, X. Cao and S.E. Jacobsen, 2002. Control of CpNpG DNA methylation by the kryptonite histone H3 methyltransferase. Nature, 416: 556-560. PubMed |
34: Jensen, T.J., R.J. Wozniak, K.E. Eblin, S.M. Wnek, A.J. Gandolfi and B.W. Futscher, 2009. Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol. Applied Pharmacol, 235: 39-46. CrossRef |
35: Jones, P.A. and S.B. Baylin, 2002. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3: 415-428. CrossRef | PubMed | Direct Link |
36: Karavoltsos, S., A. Sakellari, N. Mihopoulos, M. Dassenakis and M.J. Scoullos, 2008. Evaluation of the quality of drinking-water in regions of Greece. Desalination, 224: 317-329. Direct Link |
37: Kasprzak, K.S. and G.S. Buzard, 2000. The Role of Metals in Oxidative Damage and Redox Cell-Signaling Derangements. In: Molecular Biology and Toxicology of Metals, Zalups, R.K. and J. Koropatnick (Eds.). Taylor and Francis, London, pp: 477-527.
38: Ke, Q., T.P. Ellen and M. Costa, 2008. Nickel compounds induce histone ubiquitination by inhibiting histone deubiquitinating enzyme activity. Toxicol. Applied Pharmacol., 228: 190-199. CrossRef |
39: Laden, K. and C.B. Felger, 1988. Antiperspirants and Deodorants. Marcel Dekker, New York.
40: Leader, J.E., C. Wang, M. Fu and R.G. Pestell, 2006. Epigenetic regulation of nuclear steroid receptors. Biochem. Pharmacol., 72: 1589-1596. CrossRef |
41: Lee, Y., L. Broday and M. Costa, 1998. Effects of nickel on DNA methyltransferase activity and genomic DNA methylation levels. Mutat. Res., 415: 213-218.
42: Leivadara, S.V., A.D. Nikolaou and T.D. Lekkas, 2008. Determination of organic compounds in bottled waters. Food Chem., 108: 277-286. CrossRef |
43: Li, R., Y.Y. Shugart, W. Zhou, Y. An and Y. Yang et al., 2009. Common genetic variations of the cytochrome P450 1A1 gene and risk of hepatocellular carcinoma in a Chinese population. Eur. J. Cancer, 45: 1239-1247. Direct Link |
44: Lukusa, T. and J.P. Fryns, 2008. Human chromosome fragility. Biochim. Biophys. Acta, 1779: 3-16. PubMed |
45: Majumder, S., H. Kutay, J. Datta, D. Summers, S.T. Jacob and K. Ghoshal, 2006. Epigenetic regulation of metallothionein-i gene expression: Differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins. J. Cell. Biochem., 97: 1300-1316. PubMed |
46: Mohammadi, A., A. Vaziri Gohar and M.R. Shakibaie, 2008. Mutations in tumor suppressor TP53 gene in formalin- fixed, paraffin embedded tissues of Squamous Cell Carcinoma (SCC) of lung cancer. Am. J. Biochem. Biotehcnol., 4: 1-6. CrossRef | Direct Link |
47: Melnikova, V.O. and H.N. Ananthaswamy, 2005. Cellular and molecular events leading to the development of skin cancer. Mutat. Res. Fundam. Mol. Mechanisms Mutagenesis, 571: 91-106. CrossRef | Direct Link |
48: Monsef, N., L. Helczynski, A. Lundwall, S. Pahlman and A. Bjartell, 2007. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands. Prostate, 67: 1219-1229. PubMed |
49: Nebert, D.W., A.L. Roe, M.Z. Dieter, W.A. Solis, Y. Yang and T.P. Dalton, 2000. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control and apoptosis. Biochem. Pharmacol., 59: 65-85. PubMed |
50: Nielsen, G.D., U. Soderberg, P.J. Jorgensen, D.M. Templeton, S.N. Rasmussen, K.E. Andersen and P. Grandjean, 1999. Absorption and retention of nickel from drinking-water in relation to food intake and nickel sensitivity. Toxicol. Applied Pharmacol., 154: 67-75. Direct Link |
51: Patterson, T.J., M. Ngo, P.A. Aronov, T.V. Reznikova, P.G. Green and R.H. Rice, 2003. Biological activity of inorganic arsenic and antimony reflects oxidation state in cultured human keratinocytes. Chem. Res. Toxicol., 16: 1624-1631. Direct Link |
52: Ravanat, J.L., T. Douki and J. Cadet, 2001. Direct and indirect effects of UV radiation on DNA and its components. J. Photochem. Photobiol. Biol., 63: 88-102. CrossRef |
53: Rayman, M.P., 2000. The importance of selenium to human health. Lancet, 356: 233-241. CrossRef | PubMed | Direct Link |
54: Asadikaram, G., M. Mirzai, N. Naimi and R. Dargahi, 2008. Removal of arsenic using Acetobacter Xylinum cellulose. J. Biol. Sci., 8: 209-212. CrossRef |
55: Rossman, T.G., A.N. Uddin and F.J. Burns, 2002. Arsenite cocarcinogenesis: An animal model derived from genetic toxicology studies. Environ. Health. Perspect., 110: 749-752. PubMed | Direct Link |
56: Rossman, T.G., A.N. Uddin, F.J. Burns and M.C. Bosland, 2001. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: An animal model for arsenic carcinogenesis. Toxicol. Applied Pharmacol., 176: 64-71. CrossRef |
57: Sarafanov, A.G., T.I. Todorov, A. Kajdacsy-Balla, M.A. Gray, V. Macias and J.A. Centeno, 2008. Analysis of iron, zinc, selenium and cadmium in paraffin-embedded prostate tissue specimens using inductively coupled plasma mass-spectrometry. J. Trace Element Med. Biol., 22: 305-314. CrossRef |
58: Satoh, E., I. Yasuda, T. Yamada Y. Suzuki and T. Ohyashiki, 2007. Involvement of NO generation in aluminum-induced cell death. Biol. Pharm. Bull., 30: 1390-1394. Direct Link |
59: Schnekenburger, M., L. Peng and A. Puga, 2007. HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation. Biochim. Biophys. Acta Gene Struct. Expression, 1769: 569-578. CrossRef |
60: Sell, S., 2004. Stem cell origin of cancer and differentiation therapy. Crit. Rev. Oncol./Hematol., 51: 1-28. CrossRef | Direct Link |
61: Stellman, S.D., M.V. Djordjevic, J.A. Britton, J.E. Muscat and M.L. Citron et al., 2000. Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol. Biomarks Prev., 9: 1241-1249. Direct Link |
62: Sun, X., J.M. Fontaine, I. Bartl, B. Behnam, M.J. Welsh and R. Benndorf, 2007. Induction of Hsp22 (HspB8) by estrogen and the metalloestrogen cadmium in estrogen receptor-positive breast cancer cells. Cell Stress Chaperones, 2: 307-319. PubMed |
63: Suzuki, K.T., A. Katagiri, Y. Sakuma, Y. Ogra and M. Ohmichi, 2004. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats. Toxicol. Applied Pharmacol., 198: 336-344. PubMed |
64: Tamaru, H. and E.U. Selker, 2001. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature, 414: 277-283. CrossRef |
65: Thomas, G., 1992. MAP kinase by any other name smells just as sweet. Cell, 68: 3-6. PubMed |
66: Vahter, M., 2002. Mechanisms of arsenic biotransformation. Toxicology, 181-182: 211-217. CrossRef |
67: Vahter, M., 2000. Genetic polymorphism in the biotransformation of inorganic and its role in toxicity. Toxicol. Lett., 112-113: 209-217. CrossRef |
68: Vaziri Gohar, A., A. Mohammadi and M. Heidari, 2007. Molecular Genetics of Cancer. Samer Publication, Tehran, Iran.
69: Vaziri Gohar, A. and A. Mohammadi, 2009. A simple method for DNA extraction from formalin-fixed Paraffin embedded tissue blocks. Protocol Online.
70: Vogelstein, B. and K.W. Kinzler, 2004. Cancer genes and the pathways they control. Nat. Med., 10: 789-799. PubMed |
71: Wei, Y.D., K. Tepperman, M.Y. Huang, M.A. Sartor and A. Puga, 2004. Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. J. Biol. Chem., 279: 4110-4119. Direct Link |
72: WHO, 2005. Nickel in drinking-water, 2005. Background Document for Development of WHO Guidelines for Drinking-Water Quality. http://www.who.int/water_sanitation_health/gdwqrevision/nickel2005.pdf.
73: WHO, 2003. Arsenic in drinking-water. Background Document for Development of WHO Guidelines for Drinking-Water Quality. http://www.who.int/mediacentre/factsheets/fs210/en/.
74: Wu, J.P., L.W. Chang, H.T. Yao, H. Chang and H.T. Tsai et al., 2008. Involvement of oxidative stress and activation of aryl hydrocarbon receptor in elevation of CYP1A1 expression and activity in lung cells and tissues by arsenic: An in vitro and in vivo study. Toxicol. Sci., 107: 385-393. CrossRef | Direct Link |
75: Xiang, N., R. Zhao, G. Song and W. Zhong, 2008. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. Carcinogenesis, 29: 2175-2181. CrossRef |
76: Zhang, Q., T. Kluz, K. Salnikow and M. Costa, 2002. Comparison of the cytotoxicity, cellular uptake and DNA-protein crosslinks induced by potassium chromate in lymphoblast cell lines derived from three individuals. Biol. Trace Element Res., 86: 11-22. PubMed |
77: Zhang, R.Y., Y. Lui, D.W. Pang, R.X. Cai and Y.P. Qi, 2002. Spectroscopic and voltammetric study on the binding of aluminium (III) to DNA. Anal. Sci., 18: 761-766. Direct Link |
78: Zhitkovich, A., V. Voitkun and M. Costa, 1995. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis, 16: 907-913.
79: Zou, Y., P. Niu, J. Yang, J. Yuan, T. Wu and X. Chen, 2008. The JNK signaling pathway is involved in sodium-selenite-induced apoptosis mediated by reactive oxygen in HepG2 cells. Cancer Biol. Ther., 7: 689-696. PubMed |
80: Kinzler, K.W. and B. Vogelstein, 1997. Cancer-susceptibility genes: Gatekeepers and caretakers. Nature, 386: 761-763. Direct Link |
81: Yu, M.W., I.S. Horng, K.H. Hsu, Y.C. Chiang, Y.F. Liaw and C.J. Chen, 1999. Plasma selenium levels and the risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am. J. Epidemiol., 150: 367-374. Direct Link |
82: Zhang, M. and J.M. Rosen, 2006. Stem cells in the etiology and treatment of cancer. Curr. Opin. Genet. Dev., 16: 60-64.
83: Cowell, J.K., 2001. Molecular Genetics of Cancer. 2nd Edn., BIOS Scientific Publishers Ltd., Oxford, UK.
|
|
|
 |